Recession and Market Maturity Driving Lasik Prices Down

This post was written by admin
Posted Under: Trends

In Mature LASIK Market, Competition, Recession Bring Down Prices

Up to half of the world’s population will need corrective vision at some stage in their lives. But only about 10% of them will be diagnosed and treated, leaving an enormous potential pool of customers. Fulfilling this demand for both traditional and advanced refractive vision correction (RVC) treatments will propel the ophthalmology market to become one of the largest healthcare sectors over the next ten years. According to a new report from leading life science market research publisher Kalorama Information, “Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Edition,” the popular RVC procedure LASIK is performed between 1.1 and 1.4 million per year in the U.S. alone and physician fees exceed $2 billion per year.

LASIK surgery was first introduced more than ten years ago and is now a mature industry with many providers and healthy 95% patient satisfaction rate. But this pool of candidates is diminishing in part due to fears of falling in the 2-5% of patients who experience problems and partly due to the current recession — in early 2009 some clinics reported a 50% decrease in surgeries compared to early 2008. Patients are waiting out the economy before spending money on elective procedures.

“The U.S. LASIK market is approaching saturation and that’s great for consumers,” says Bruce Carlson, publisher of Kalorama Information. “Competition between vision care centers, ophthalmologist offices, and eye clinics has pushed prices down making LASIK procedures affordable to many more prospective patients. Special advertised pricing, promotions, and payment and financing plans are also bringing in new patients.”

Given the complexities of RVC’s fragmented technologies, operating as a solo practice is increasingly challenging and competitive realities have triggered the growth of vision care centers. While a few practices are high volume LASIK/laser producers, the vast majority are just getting by.

The expansion of vision care centers will continue as more medical professionals find this a more financially appealing alternative. With this growth, some centers are also expanding their provider services to diversify their RVC business, adding multiple treatment modalities.

During 2008, the world RVC market showed an overall decline of 0.4% globally from $5.86 billion to $5.83 billion. Although the number of procedures increased from 2.99 million to 3.01 million, average procedure fees declined in 2008, primarily in the United States due to the recession and the competitive environment. Meanwhile, sales are going up globally as $1000 procedures in countries like South Africa, Egypt, and Kenya are attracting international travelers for ‘LASIK vacations.’

Kalorama Information’s new report, “Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Edition,” covers all the latest trends and issues and explores the changing competitive dynamics caused by rapidly evolving technological discoveries. The market analysis is comprised of two major sectors: refractive vision correction treatments and management of major eye diseases. For further information visit: http://www.kaloramainformation.com/redirect.asp?progid=70705&productid=2271479.

About Kalorama Information

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. Follow us on Twitter: www.twitter.com/KaloramaInfo

Originally posted. August 2, 2009

Add a Comment

required, use real name
required, will not be published
optional, your blog address

*

casino online casinos cordarone drug Buy viagra canada lamisil liquid buy propecia online bisoprolol fumarate diabetes buy kamagra online infant motrin cold dosage buy zithromax online uroxatral treatment bph Buy Azithromycin Online candesartan chemistry alt sgpt Kamagra oral jelly indinavir hplc zorbax buy finasteride online diovan price in usa buy finasteride online decomposition of dilantin free slots online free model kit 8564 lioresal intrathecal buy propecia online ritonavir and polymorph buy clomiphene online azithromycin dosing children no deposit bonus casino fansidar dosage buy lasix online coumadin intracranial berry aneurysms Kamagra oral jelly koop ticlopidine buy kamagra online esomeprazole and adverse events buy furosemide online why tenormin vs lopressor Buy furosemide online lotemax nsaid's


DIRECTORY OF LASIK DOCTORS AND EYE CARE CENTERS BY CITY

Albany AtlantaBaltimoreBeverly HillsBostonChicagoCincinnatiConnecticutDallasDenverDetroitFort WorthHoustonIndianapolisKansas CityLas Vegas Los Angeles Long Beach Miami MilwaukeeMinneapolisNew York OaklandOrlandoPhiladelphia PittsburghPhoenixSan Antonio San Diego San Francisco San Jose Syracuse Tampa Washington DC

DISCLAIMER OF MEDICAL AND LASIK LIABILITY



You understand and agree that LASIKBOOK.COM does not provide medical advice or endorsements.

A. LASIKBOOK.COM does not provide medical advice. Unless explicitly stated otherwise, all content on this website is the opinion or information of its author, not LASIKBOOK.COM. This website is not a substitute for medical advice. Always contact your own eye doctor or other professional healthcare provider if you have a question concerning your or your family's health.

B. LASIKBOOK.COM does not recommend or endorse the products or services of others. LASIKBOOK.COM does not recommend or endorse any specific tests, drugs, devices, products, services, physicians, or medical institutions that may be mentioned or referenced on this website. Any advertisers who purchase banners or otherwise support LASIKBOOK.COM and this Website have no influence on the editorial content or presentation and any such advertisements are not implied or express endorsements of any product, service, or company.

RELIANCE ON ANY INFORMATION ON THIS WEBSITE IS AT YOUR OWN RISK. LASIKBOOK.COM IS NOT RESPONSIBLE OR LIABLE FOR ANY ADVICE, COURSE OF TREATMENT, DIAGNOSIS, DRUG AND DEVICE APPLICATION OR OTHER INFORMATION, SERVICES, OR PRODUCTS THAT YOU OBTAIN THROUGH THIS SITE.


buy lasix online misoprostol as abortifacient buy clomid online bl v2 veetids buy flagyl online arizona aguila accutane legal form buy cipro online list of doctors that prescribe isotretinoin buy nolvadex online can augmentin help conjunctivitis buy xenical online antimicrobial dosing parameters for furazolidone